Novel Methods For EV Isolation and Their Use in a Pilot Liver Disease Biomarker Discovery Study
Shannon Pendergrast,
Chief Scientific Officer,
Ymir Genomics
We will describe several novel products and methods for the rapid and effective isolation of biofluid extracellular vesicles (EVs). Also, the use of one such method to discover novel EV-associated urine biomarkers for liver disease will be presented.
|
|
